Literature DB >> 2126206

Botulinum neurotoxin type A: sequence of amino acids at the N-terminus and around the nicking site.

B R DasGupta1, M L Dekleva.   

Abstract

Clostridium botulinum synthesizes the type A botulinum neurotoxin (NT) as a approximately 150 kDa single chain protein. Post-translational proteolytic processing yields a approximately 150 kDa dichain protein composed of a approximately 50 kDa light and approximately 100 kDa heavy chain, which has higher toxicity. Trypsin's action mimics the endogenous proteolytic processing. The proteolytic cleavages could occur at 4 sites. We have examined 2 such sites and defined the peptide sequences before and after proteolytic processing. The N-terminal residues of the newly synthesized approximately 150 kDa single chain NT, Pro-Phe-Val-Asn-Lys-, remain intact at the N-terminus of the approximately 50 kDa light chain generated either in the clostridial culture or in vitro with trypsin or with a protease purified from the homologous bacterial culture. The clostridial protease cleaves the single chain NT in vitro, at 1/3 the distance from its N-terminus, on the amino side of Gly of the sequence -Gly-Tyr-Asn-Lys-Ala-Leu-Asn-Asp-Leu- before cleaving the bond Lys-Ala at a slower rate. The data indicate that the dichain NT is formed in the bacterial culture in at least 2 steps. Cleavage at X-Gly produces a approximately 100 kDa heavy chain-like fragment which is then truncated; cleavage 4 residues downstream at Lys-Ala, and excision of the tetrapeptide Gly-Tyr-Asn-Lys, generates the mature heavy chain with Ala as its N-terminal residue. The approximately 100 kDa heavy chain generated in vitro, by nicking the single chain NT with trypsin, also has Ala-Leu-Asn- as the N-terminal residues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126206     DOI: 10.1016/0300-9084(90)90048-l

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  17 in total

1.  Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.

Authors:  Bibhuti R Dasgupta; Babu S Antharavally; William Tepp; Mary L Evenson
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

2.  Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.

Authors:  Dongxia Wang; Jakub Baudys; Yiming Ye; Jon C Rees; John R Barr; James L Pirkle; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2012-09-24       Impact factor: 3.365

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

4.  Botulinum type A neurotoxin digested with pepsin yields 132, 97, 72, 45, 42, and 18 kD fragments.

Authors:  J A Gimenez; B R DasGupta
Journal:  J Protein Chem       Date:  1993-06

Review 5.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases.

Authors:  V M Gordon; S H Leppla
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.

Authors:  Dongxia Wang; Joan Krilich; Jakub Baudys; John R Barr; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2014-09-16       Impact factor: 3.365

7.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

8.  Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

Authors:  Dongxia Wang; Joan Krilich; Sabine Pellett; Jakub Baudys; William H Tepp; John R Barr; Eric A Johnson; Suzanne R Kalb
Journal:  Biochim Biophys Acta       Date:  2013-10-02

9.  The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Authors:  Rahman M Mizanur; Verna Frasca; Subramanyam Swaminathan; Sina Bavari; Robert Webb; Leonard A Smith; S Ashraf Ahmed
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

10.  Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism.

Authors:  J A Giménez; M A Giménez; B R DasGupta
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.